Skip to main content
Log in

Influence of diltiazem on the behavior of zolpidem-treated mice in the elevated-plus maze test

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary.

The present study was undertaken to investigate the effect of diltiazem, a L-type calcium channel blocker (CCB), on the behavior of zolpidem-treated mice in the elevated plus-maze (EPM). Atypical benzodiazepine zolpidem significantly increased the percentage of open arm entries without influencing the total entries and total distance and average speed at the dose of 5 mg/kg (p.o.). Co-administration of zolpidem (2 mg/kg, p.o.) and diltiazem (5, 10 and 20 mg/kg, p.o.) significantly increased both the time spent and arm entries in the open arms without influencing the total entries and spontaneous activity notwithstanding that zolpidem at dose up to 2 mg/kg (p.o.) and diltiazem at dose up to 20 mg/kg (p.o.) did not show any effects on mice behavior in EPM. Zolpidem also attenuated the anxiogenic effect of 1-(3-Chlorophenyl)piperazine (mCPP, 0.7 mg/kg, i.p.) and 5-hydroxytryptophan (5-HTP, 30 mg/kg, i.p.). Even though the zolpidem at 1 mg/kg and diltiazem at 5 mg/kg were ineffective on mCPP-induced anxiety, respectively, the co-administration of zolpidem (1 mg/kg, i.p.) and diltiazem (5 mg/kg, p.o.) showed inhibitory effect on mCPP-induced anxiety in mice. These results suggested that diltiazem, a L-type CCB may augment the anxiolytic-like effect of zolpidem and also indicated that calcium channel modulation maybe involved in the anxiolytic-like properties of zolpidem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • J Auta E Romeo A Kozikowski D Ma E Costa A Guidotti (1993) ArticleTitleParticipation of mitochondrial diazepam binding inhibitor receptors in the anticonflict, antineophobic and anticonvulsant action of 2-aryl-3-indoleacetamide and imidazopyridine derivatives J Pharmacol Exp Ther 265 649–656 Occurrence Handle8098760 Occurrence Handle1:CAS:528:DyaK3sXks1aqtr4%3D

    PubMed  CAS  Google Scholar 

  • D Benjamin H Lal LR Meyerson (1990) ArticleTitleThe effects of 5-HT1B characterizing agents in the mouse elevated plus-maze Life Sci 47 195–203 Occurrence Handle1975081 Occurrence Handle10.1016/0024-3205(90)90320-Q Occurrence Handle1:CAS:528:DyaK3cXlsVGhtrw%3D

    Article  PubMed  CAS  Google Scholar 

  • G Biala B Weglinska (2005) ArticleTitleBlockade of the expression of mecamylamine-precipitated nicotine withdrawal by calcium channel antagonists Pharmacol Res 51 483–488 Occurrence Handle15749464 Occurrence Handle1:CAS:528:DC%2BD2MXhvFyntLc%3D

    PubMed  CAS  Google Scholar 

  • SJ Czuczwar A Chodkowska Z Kleinrok U Malek E Jagiello-Wojtowicz (1990) ArticleTitleEffects of calcium channel inhibitors upon the efficacy of common antiepileptic drugs Eur J Pharmacol 176 75–83 Occurrence Handle2311661 Occurrence Handle10.1016/0014-2999(90)90134-R Occurrence Handle1:CAS:528:DyaK3cXhtlagtb8%3D

    Article  PubMed  CAS  Google Scholar 

  • MF Davies ES Onaivi SW Chen PA Maguire NF Tsai GH Loew (1994) ArticleTitleEvidence for central benzodiazepine receptor heterogeneity from behavior tests Pharmacol Biochem Behav 49 47–56 Occurrence Handle7816889 Occurrence Handle10.1016/0091-3057(94)90455-3 Occurrence Handle1:CAS:528:DyaK2cXlvFGktLc%3D

    Article  PubMed  CAS  Google Scholar 

  • GR Dawson MD Tricklebank (1995) ArticleTitleUse of the elevated plus maze in the search for novel anxiolytic agents Trends Pharmacol Sci 16 33–36 Occurrence Handle7762079 Occurrence Handle10.1016/S0165-6147(00)88973-7 Occurrence Handle1:CAS:528:DyaK2MXkvVejtrg%3D

    Article  PubMed  CAS  Google Scholar 

  • H Depoortere B Zivkovic KG Lloyd DJ Sanger G Perrault SZ Langer G Bartholini (1986) ArticleTitleZolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects J Pharmacol Exp Ther 237 649–658 Occurrence Handle2871178 Occurrence Handle1:CAS:528:DyaL28XktlGnt7Y%3D

    PubMed  CAS  Google Scholar 

  • SJ Dolin HJ Little (1986) ArticleTitleAugmentation by calcium channel antagonists of general anaesthetic potency in mice Br J Pharmacol 88 909–914 Occurrence Handle2943355 Occurrence Handle1:CAS:528:DyaL28XltVynsro%3D

    PubMed  CAS  Google Scholar 

  • SJ Dolin TL Patch M Rabbani PV Taberner HJ Little (1991) ArticleTitleDifferential interactions between benzodiazepines and the dihydropyridines, nitrendipine and Bay K 8644 Neuropharmacology 30 217–224 Occurrence Handle1712926 Occurrence Handle10.1016/0028-3908(91)90148-5 Occurrence Handle1:CAS:528:DyaK3MXhslOqsrs%3D

    Article  PubMed  CAS  Google Scholar 

  • MB Gatch (2003) ArticleTitleDiscriminative stimulus effects of m-chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety Life Sci 73 1347–1367 Occurrence Handle12850497 Occurrence Handle10.1016/S0024-3205(03)00422-3 Occurrence Handle1:CAS:528:DC%2BD3sXltF2ntrc%3D

    Article  PubMed  CAS  Google Scholar 

  • EL Gibson AM Barnfield G Curzon (1994) ArticleTitleEvidence that mCPP-induced anxiety in the plus-maze is mediated by postsynaptic 5-HT2C receptors but not by sympathomimetic effects Neuropharmacology 33 457–465 Occurrence Handle7984284 Occurrence Handle10.1016/0028-3908(94)90076-0 Occurrence Handle1:CAS:528:DyaK2cXktVSkt78%3D

    Article  PubMed  CAS  Google Scholar 

  • G Griebel DJ Sanger G Perrault (1996a) ArticleTitleThe use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (omega1) selective, benzodiazepine receptor ligands Psychopharmacology 124 245–254 Occurrence Handle10.1007/BF02246664 Occurrence Handle1:CAS:528:DyaK28XjsFOrtLk%3D

    Article  CAS  Google Scholar 

  • G Griebel DJ Sanger G Perrault (1996b) ArticleTitleFurther evidence for differences between non-selective and BZ-1 (omega1) selective, benzodiazepine receptor ligands in murine models of “state” and “trait” anxiety Neuropharmacology 35 1081–1091 Occurrence Handle10.1016/S0028-3908(96)00080-9 Occurrence Handle1:CAS:528:DyaK2sXnsFKrsA%3D%3D

    Article  CAS  Google Scholar 

  • G Griebel DJ Sanger G Perrault (1996c) ArticleTitleThe mouse defense test battery: evaluation of the effects of non-selective and BZ-1 (omega1) selective, benzodiazepine receptor ligands Behav Pharmacol 7 560–572 Occurrence Handle1:CAS:528:DyaK2sXmsF2qsQ%3D%3D

    CAS  Google Scholar 

  • G Griebel G Perrault DJ Sanger (1998) ArticleTitleLimited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents J Psychopharmacol 12 356–365 Occurrence Handle10065909 Occurrence Handle1:CAS:528:DyaK1MXpsVSmsw%3D%3D

    PubMed  CAS  Google Scholar 

  • G Griebel G Perrault V Letang P Granger P Avenet H Schoemaker DJ Sanger (1999) ArticleTitleNew evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes Psychopharmacology 146 205–213 Occurrence Handle10525757 Occurrence Handle10.1007/s002130051108 Occurrence Handle1:CAS:528:DyaK1MXntlOmtbo%3D

    Article  PubMed  CAS  Google Scholar 

  • JP Huidobro-Toro CF Valenzuela RA Harris (1996) ArticleTitleModulation of GABAA receptor function by G protein-coupled 5-HT2C receptors Neuropharmacology 35 1355–1363 Occurrence Handle9014152 Occurrence Handle10.1016/S0028-3908(96)00084-6 Occurrence Handle1:CAS:528:DyaK2sXnsFKlsw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • E Jankowska O Pucilowski W Kostowski (1991) ArticleTitleChronic oral treatment with diltiazem or verapamil decreases isolation-induced activity impairment in elevated plus maze Behav Brain Res 43 155–158 Occurrence Handle1867756 Occurrence Handle10.1016/S0166-4328(05)80065-8 Occurrence Handle1:CAS:528:DyaK3MXkvVGhtrc%3D

    Article  PubMed  CAS  Google Scholar 

  • DJ Knapp DH Overstreet SS Moy GR Breese (2004) ArticleTitleSB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats Alcohol 32 101–111 Occurrence Handle15163561 Occurrence Handle10.1016/j.alcohol.2003.08.007 Occurrence Handle1:CAS:528:DC%2BD2cXksVCitLY%3D

    Article  PubMed  CAS  Google Scholar 

  • GA Kennett P Whitton K Shah G Curzon (1989) ArticleTitleAnxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists Eur J Pharmacol 164 445–454 Occurrence Handle2767117 Occurrence Handle10.1016/0014-2999(89)90252-5 Occurrence Handle1:CAS:528:DyaL1MXkslSrs74%3D

    Article  PubMed  CAS  Google Scholar 

  • GA Kennett MD Wood F Bright B Trail G Riley V Holland KY Avenell T Stean N Upton S Bromidge IT Forbes AM Brown DN Middlemiss TP Blackburn (1997) ArticleTitleSB 242084, a selective and brain penetrant 5-HT2C receptor antagonist Neuropharmacology 36 609–620 Occurrence Handle9225286 Occurrence Handle10.1016/S0028-3908(97)00038-5 Occurrence Handle1:CAS:528:DyaK2sXktlSmu7Y%3D

    Article  PubMed  CAS  Google Scholar 

  • E Lobarinas JL Falk (2000) ArticleTitleComparison of benzodiazepines and the non-benzodiazepine agents zolpidem and zaleplon with respect to anxiolytic action as measured by increases in hypertonic NaCl-solution drinking in rats Psychopharmacology 149 176–180 Occurrence Handle10805613 Occurrence Handle10.1007/s002139900354 Occurrence Handle1:CAS:528:DC%2BD3cXjtFWnur8%3D

    Article  PubMed  CAS  Google Scholar 

  • JR Martin TM Ballard GA Higgins (2002) ArticleTitleInfluence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety Pharmacol Biochem Behav 71 615–625 Occurrence Handle11888553 Occurrence Handle10.1016/S0091-3057(01)00713-4 Occurrence Handle1:CAS:528:DC%2BD38XhvVChtbY%3D

    Article  PubMed  CAS  Google Scholar 

  • RM McKernan TW Rosahl DS Reynolds C Sur KA Wafford JR Atack S Farrar J Myers G Cook P Ferris L Garrett L Bristow G Marshall A Macaulay N Brown O Howell KW Moore RW Carling LJ Street JL Castro CI Ragan GR Dawson PJ Whiting (2000) ArticleTitleSedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype Nat Neurosci 3 587–592 Occurrence Handle10816315 Occurrence Handle10.1038/75761 Occurrence Handle1:CAS:528:DC%2BD3cXjsF2nu70%3D

    Article  PubMed  CAS  Google Scholar 

  • SS Moy DJ Knapp HE Criswell GR Breese (1997) ArticleTitleFlumazenil blockade of anxiety following ethanol withdrawal in rats Psychopharmacology 131 354–360 Occurrence Handle9226737 Occurrence Handle10.1007/s002130050303 Occurrence Handle1:CAS:528:DyaK2sXktF2lu78%3D

    Article  PubMed  CAS  Google Scholar 

  • M Nazar M Jessa A Plaznik (1997) ArticleTitleBenzodiazepine-GABAA receptor complex ligands in two models of anxiety J Neural Transm 104 733–746 Occurrence Handle9444572 Occurrence Handle10.1007/BF01291890 Occurrence Handle1:CAS:528:DyaK2sXnsVymsLk%3D

    Article  PubMed  CAS  Google Scholar 

  • S Pellow P Chopin SE File M Briley (1985) ArticleTitleValidation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat J Neurosci Methods 14 149–167 Occurrence Handle2864480 Occurrence Handle10.1016/0165-0270(85)90031-7 Occurrence Handle1:STN:280:DyaL28%2Fht12htw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • G Perrault E Morel DJ Sanger B Zivkovic (1990) ArticleTitleDifferences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics Eur J Pharmacol 187 487–494 Occurrence Handle1981555 Occurrence Handle10.1016/0014-2999(90)90375-G Occurrence Handle1:CAS:528:DyaK3MXlsFKlsA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • O Pucilowski (1992) ArticleTitlePsychopharmacological properties of calcium channel inhibitors Psychopharmacology (Berl) 109 12–29 Occurrence Handle10.1007/BF02245476 Occurrence Handle1:CAS:528:DyaK3sXit1CktL4%3D

    Article  CAS  Google Scholar 

  • O Pucilowski W Kostowski (1991) ArticleTitleIncreased anxiety during ethanol and diazepam withdrawal in rats: effects of diltiazem and nicardipine Alcohol Clin Exp Res 15 331–334

    Google Scholar 

  • DG Rainnie (1999) ArticleTitleSerotonergic modulation of neurotransmission in the rat basolateral amygdala J Neurophysiol 82 69–85 Occurrence Handle10400936 Occurrence Handle1:CAS:528:DyaK1MXkvFKqurs%3D

    PubMed  CAS  Google Scholar 

  • U Rudolph F Crestani D Benke I Brunig JA Benson JM Fritschy JR Martin H Bluethmann H Mohler (1999) ArticleTitleBenzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes Nature 401 796–800 Occurrence Handle10548105 Occurrence Handle10.1038/44579 Occurrence Handle1:CAS:528:DyaK1MXntFaru70%3D

    Article  PubMed  CAS  Google Scholar 

  • DJ Sanger B Zivkovic (1986) ArticleTitleThe discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic Psychopharmacology 89 317–322 Occurrence Handle2873608 Occurrence Handle1:CAS:528:DyaL28XltVygtrg%3D

    PubMed  CAS  Google Scholar 

  • MM Savic DI Obradovic ND Ugresic JM Cook W Yin DR Bokonjic (2004) ArticleTitleBidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt Pharmacol Biochem Behav 79 279–290 Occurrence Handle15501303 Occurrence Handle10.1016/j.pbb.2004.07.013 Occurrence Handle1:CAS:528:DC%2BD2cXovV2gtro%3D

    Article  PubMed  CAS  Google Scholar 

  • J Serrats G Mengod R Cortes (2005) ArticleTitleExpression of serotonin 5-HT2C receptors in GABAergic cells of the anterior raphe nuclei J Chem Neuroanat 29 83–91 Occurrence Handle15652696 Occurrence Handle10.1016/j.jchemneu.2004.03.010 Occurrence Handle1:CAS:528:DC%2BD2MXkvFemtw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • S Sonkusare K Srinivasan C Kaul P Ramarao (2005) ArticleTitleEffect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats Life Sci 77 1–14 Occurrence Handle15848214 Occurrence Handle10.1016/j.lfs.2004.10.036 Occurrence Handle1:CAS:528:DC%2BD2MXjsVeku7c%3D

    Article  PubMed  CAS  Google Scholar 

  • P Soubrie (1989) ArticleTitleNeuropsychological profiles of calcium antagonists Fundam Clin Pharmacol 3 IssueIDSuppl 71s–78s Occurrence Handle2693293 Occurrence Handle10.1111/j.1472-8206.1989.tb00477.x

    Article  PubMed  Google Scholar 

  • H Takahashi M Yoshimoto H Higuchi T Shimizu Y Hishikawa (1999) ArticleTitleDifferent effects of L-type and T-type calcium channel blockers on the hypnotic potency of triazolam and zolpidem in rats Eur Neuropsychopharmacol 9 317–321 Occurrence Handle10422892 Occurrence Handle10.1016/S0924-977X(98)00051-0 Occurrence Handle1:CAS:528:DyaK1MXksFWrs7w%3D

    Article  PubMed  CAS  Google Scholar 

  • X Zhao XY Cui BQ Chen QP Chu HY Yao BS Ku YH Zhang (2004) ArticleTitleTetrandrine, a bisbenzylisoquinoline alkaloid from Chinese herb Radix, augmented the hypnotic effect of pentobarbital through serotonergic system Eur J Pharmacol 506 101–105 Occurrence Handle15588729 Occurrence Handle10.1016/j.ejphar.2004.10.046 Occurrence Handle1:CAS:528:DC%2BD2cXhtVGgu7bM

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cui, XY., Zhao, X., Chu, QP. et al. Influence of diltiazem on the behavior of zolpidem-treated mice in the elevated-plus maze test. J Neural Transm 114, 155–160 (2007). https://doi.org/10.1007/s00702-006-0535-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-006-0535-1

Navigation